Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ULTMANN, John E")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 55

  • Page / 3
Export

Selection :

  • and

Chromosomes and cancer: from molecules to man, [5th Annual Bristol-Myers symposium on cancer research, University of Chicago Cancer Research Center, October 18-19, 1982]ROWLEY, Janet D; ULTMANN, John E.Chromosomes and cancer: from molecules to man. Symposium. 1983, XXII-357 p, isbn 0-12-600250-9Conference Proceedings

Is Hodgkin's disease an infectious disease?WOLF, J; DIEHL, V.Annals of oncology. 1994, Vol 5, pp S105-S111, issn 0923-7534, SUP1Conference Paper

Haemopoietic growth factors and dose intensity in high-grade and intermediate-grade lymphomaPETTENGELL, R; CROWTHER, D.Annals of oncology. 1994, Vol 5, pp 133-141, issn 0923-7534, SUP2Conference Paper

Mantle-cell lymphomaDE WOLF-PEETERS, C; PITTALUGA, S.Annals of oncology. 1994, Vol 5, pp S35-S37, issn 0923-7534, SUP1Conference Paper

Prospects for the therapeutic use of antisense oligonucleotides in malignant lymphomasMAGRATH, I. T.Annals of oncology. 1994, Vol 5, pp S67-S70, issn 0923-7534, SUP1Conference Paper

The treatment of Hodgkin's diseaseROSENBERG, S. A.Annals of oncology. 1994, Vol 5, pp 17-21, issn 0923-7534, SUP2Conference Paper

Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphomaCANELLOS, G. P.Annals of oncology. 1994, Vol 5, pp 121-122, issn 0923-7534, SUP2Conference Paper

Low-grade lymphoma 1993 : state of the artHORNING, S. J.Annals of oncology. 1994, Vol 5, pp 23-27, issn 0923-7534, SUP2Conference Paper

Lymphoma complicating immunodeficiency disordersLEVINE, A. M.Annals of oncology. 1994, Vol 5, pp 29-35, issn 0923-7534, SUP2Conference Paper

Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangementWILLIAMS, M. E; SWERDLOW, S. H.Annals of oncology. 1994, Vol 5, pp S71-S73, issn 0923-7534, SUP1Conference Paper

Lymphokine receptors: a target for immunotherapy of lymphomasWALDMANN, T. A.Annals of oncology. 1994, Vol 5, pp S13-S17, issn 0923-7534, SUP1Conference Paper

Modern treatment of malignant lymphomas : a multidisciplinary approach ? The Kaplan memorial lectureBONADONNA, G.Annals of oncology. 1994, Vol 5, pp 5-16, issn 0923-7534, SUP2Conference Paper

Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entityKADIN, M. E.Annals of oncology. 1994, Vol 5, pp S25-S30, issn 0923-7534, SUP1Conference Paper

Early bone marrow transplantation in Hodgkin's diseaseARMITAGE, J. O.Annals of oncology. 1994, Vol 5, pp 161-163, issn 0923-7534, SUP2Conference Paper

Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemicWEISENBURGER, D. D.Annals of oncology. 1994, Vol 5, pp S19-S24, issn 0923-7534, SUP1Conference Paper

Pediatric lymphomas: recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhoodMURPHY, S. B.Annals of oncology. 1994, Vol 5, pp S31-S33, issn 0923-7534, SUP1Conference Paper

A reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphomaSTRAKA, C; PETTENGELL, R; PIELMEIER, A et al.Annals of oncology. 1994, Vol 5, pp S79-S84, issn 0923-7534, SUP1Conference Paper

Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma : high remission rates and reversion to negative of peripheral blood bcl-2 rearrangementMCLAUGHLIN, P; HAGEMEISTER, F. B; SWAN, F et al.Annals of oncology. 1994, Vol 5, pp 73-77, issn 0923-7534, SUP2Conference Paper

Proliferation of Reed-Sternberg cells and variants in Hodgkin's diseaseGUPTA, R. K; LISTER, T. A; BODMER, J. G et al.Annals of oncology. 1994, Vol 5, pp S117-S119, issn 0923-7534, SUP1Conference Paper

The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapyHAGEMEISTER, F. B; PURUGGANAN, R; PODOLOFF, D. A et al.Annals of oncology. 1994, Vol 5, pp 59-63, issn 0923-7534, SUP2Conference Paper

The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomasJAFFE, E. S; ZARATE-OSORNO, A; KINGMA, D. W et al.Annals of oncology. 1994, Vol 5, pp S7-S11, issn 0923-7534, SUP1Conference Paper

Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapyZAGONEL, V; BABARE, R; MEROLA, M. C et al.Annals of oncology. 1994, Vol 5, pp 127-132, issn 0923-7534, SUP2Conference Paper

Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas : results of a randomized double-blind placebo-controlled study with intensified COP-BLAM ± rhCM-CSFENGELHARD, M; GERHARTZ, H; LUDWIG, W.-D et al.Annals of oncology. 1994, Vol 5, pp 123-125, issn 0923-7534, SUP2Conference Paper

Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomasREA, D; DELECLUSE, H.-J; HAMILTON-DUTOIT, S. J et al.Annals of oncology. 1994, Vol 5, pp S113-S116, issn 0923-7534, SUP1Conference Paper

Investigation of the activation state of the X chromosome in non-Hodgkin's lymphomasGRIERSON, A. J; HAMMOND, D. W; GOEPEL, J. R et al.Annals of oncology. 1994, Vol 5, pp S47-S50, issn 0923-7534, SUP1Conference Paper

  • Page / 3